Status:
RECRUITING
Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol Use Disorder
Alcoholic Hepatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Given the severe consequences of alcohol relapse following liver transplantation for alcoholic hepatitis (AH-LT), it is critical to accurately identify alcohol use and implement alcohol interventions ...
Detailed Description
In the United States, alcoholic liver disease (ALD) is the second most common indication for liver transplant (LT). Traditionally, ALD patients have been required to complete a six-month mandatory per...
Eligibility Criteria
Inclusion
- English speaking
Exclusion
- too medically/psychiatrically ill to participate
- not able to provide informed consent due to cognitive impairment
Key Trial Info
Start Date :
November 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03845205
Start Date
November 20 2020
End Date
June 1 2027
Last Update
June 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21205